User profiles for "author:P. Van Dam"

Peter A van Dam

- Verified email at telenet.be - Cited by 14073

Pieter-Jan HH van Dam

- Verified email at cellcarta.com - Cited by 2046

[HTML][HTML] The potential and controversy of targeting STAT family members in cancer

Y Verhoeven, S Tilborghs, J Jacobs, J De Waele… - Seminars in cancer …, 2020 - Elsevier
Abstract The Signal Transducer and Activator of Transcription (STAT) family of proteins
consists of transcription factors that play a complex and essential role in the regulation of …

FGFR a promising druggable target in cancer: Molecular biology and new drugs

…, T Franchina, N Van Der Steen, P Van Dam… - Critical reviews in …, 2017 - Elsevier
Abstract Introduction The Fibroblast Growth Factor Receptor (FGFR) family consists of
Tyrosine Kinase Receptors (TKR) involved in several biological functions. Recently …

[PDF][PDF] The role of oxidative stress in neuropathy and other diabetic complications

PS Van Dam, BS Van Asbeck, DW Erkelens… - Diabetes metabolism …, 1995 - academia.edu
Reactive oxygen species (ROS) have been implicated in the pathophysiology of a large
number of diseases, and can be harmful due to their high reactivity and deleterious effects …

[PDF][PDF] Phase II randomized study of neoadjuvant everolimus plus letrozole compared with placebo plus letrozole in patients with estrogen receptor–positive breast …

J Baselga, V Semiglazov, P van Dam… - Journal of Clinical …, 2009 - researchgate.net
Purpose Cross-talk between the estrogen receptor (ER) and the phosphoinositide-3-kinase
(PI3K)/Akt/mammalian target of rapamycin (mTOR) pathways is a mechanism of resistance …

Circulating interleukin‐6 predicts survival in patients with metastatic breast cancer

…, S Junius, I Benoy, P Van Dam… - … journal of cancer, 2003 - Wiley Online Library
Abstract Interleukin‐6 (IL‐6) is a multifunctional cytokine produced by macrophages, T cells,
B cells, endothelial cells and tumour cells. Interleukin‐6 is able to promote tumour growth by …

Increased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survival

IH Benoy, R Salgado, P Van Dam, K Geboers… - Clinical Cancer …, 2004 - AACR
Purpose: The prognostic significance of serum interleukin (IL)-8 was evaluated in patients
with metastatic breast cancer. The predictive value of serum IL-8 for the presence of occult …

Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial

T Powles, M Kockx, A Rodriguez-Vida, I Duran… - Nature medicine, 2019 - nature.com
Antibodies targeting PD-1 or its ligand 1 PD-L1 such as atezolizumab, have great efficacy in
a proportion of metastatic urothelial cancers,. Biomarkers may facilitate identification of these …

Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients

…, M Van Gramberen, J Decloedt, P Van Dam - Gynecologic …, 1998 - Elsevier
Objective. This study was aimed at comparison of neoadjuvant chemotherapy with primary
debulking surgery in advanced ovarian carcinoma. Methods. Retrospective analysis of 285 …

[HTML][HTML] Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic breast cancer

…, C Colpaert, I Benoy, P Huget, P Van Dam… - British journal of …, 2002 - nature.com
Plasma levels of D-dimer are elevated in cancer patients. Activation of the extrinsic
coagulation system and the fibrinolytic cascade within a tumour is thought to be related with …

Increased Angiogenesis and Lymphangiogenesis in Inflammatory versus Noninflammatory Breast Cancer by Real-Time Reverse Transcriptase-PCR Gene …

…, GG Van den Eynden, I Benoy, P Van Dam… - Clinical cancer …, 2004 - AACR
Purpose: Inflammatory breast cancer is a distinct and aggressive form of locally advanced
breast cancer with unique clinical and pathological features. Recently, histologic evidence of …